Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001076809-25-000052
Filing Date
2025-05-15
Accepted
2025-05-15 16:17:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7278
  Complete submission text file 0001076809-25-000052.txt   9000
Mailing Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019
Business Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019 212-808-7308
GLAZER CAPITAL, LLC (Filed by) CIK: 0001076809 (see all company filings)

EIN.: 134032491 | State of Incorp.: DE
Type: SCHEDULE 13G

Mailing Address 2 PELICAN DR. FORT LAUDERDALE FL 33301
Business Address 2 PELICAN DR. FORT LAUDERDALE FL 33301 954-870-3104
Drugs Made In America Acquisition Corp. (Subject) CIK: 0002028614 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94909 | Film No.: 25953549
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)